https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accounts-receivable https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accretion-amortization-of-discounts-and-premiums-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accrued-bonuses-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accrued-employee-benefits-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accrued-royalties-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-contingent-assets-and-liabilities-recognized-asset https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability-1 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/acquisitions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/adjustment-to-additional-paid-in-capital-income-tax-effect-from-share-based-compensation-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/adjustments-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/advertising-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/allocated-share-based-compensation-expense-net-of-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/amended-reports-10-k https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/amended-reports-10-q https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/amortization https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/amortization-of-financing-costs-and-discounts https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-amortized-cost https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-maturities-amortized-cost https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-amortized-cost-basis https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-maturities-next-rolling-twelve-months-fair-value https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-amortized-cost https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-maturities-within-one-year-fair-value https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-gross-unrealized-gain https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-gross-unrealized-losses https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/available-for-sale-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-contingent-consideration-at-fair-value https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-contingent-consideration-at-fair-value-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-contingent-consideration-at-fair-value-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-assets-acquired-liabilities-assumed-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-current-assets-cash-and-cash-equivalents https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-current-assets-marketable-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-current-assets-prepaid-expense-and-other-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-current-liabilities-other-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-goodwill-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/business-acquisition-purchase-price-allocation-intangible-assets-not-amortizable https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/cash-and-cash-equivalents-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/certificates-of-deposit-at-carrying-value https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/comprehensive-income https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/convertible-debt https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/convertible-debt-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/convertible-securities-retired https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/convertible-subordinated-debt-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/convertible-subordinated-debt-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/cost-of-revenue https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/costs-and-expenses https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-carrying-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-conversion-original-debt-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-maturing-after-year-five https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-maturing-in-year-five https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-maturing-in-year-four https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-maturing-in-year-three https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-maturing-in-year-two https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-revenue https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-revenue-additions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-revenue-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-capital-loss-carryforwards https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-tax-credit-carryforwards-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-deferred-expense-capitalized-inventory-costs https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-deferred-expense-capitalized-research-and-development-costs https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-financing-arrangements https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-goodwill-and-intangible-assets-intangible-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/deferred-tax-liabilities-property-plant-and-equipment https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/depreciation https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/depreciation-and-amortization https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/effect-of-exchange-rate-on-cash-and-cash-equivalents https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/eps https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/eps-basic https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/fair-value-assets-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/fair-value-assets-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/fair-value-liabilities-level-1-to-level-2-transfers-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/fair-value-liabilities-level-2-to-level-1-transfers-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-into-level https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/fair-value-measurement-with-unobservable-inputs-reconciliation-liability-transfers-out-of-level https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-future-amortization-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-useful-life-maximum https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/finite-lived-intangible-assets-useful-life-minimum https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-after-year-five https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-year-five https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-year-four https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-year-one https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-year-three https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/future-amortization-expense-year-two https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/gain-loss-on-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/goodwill https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/goodwill-acquired https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/goodwill-impaired-accumulated-impairment-loss https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/impairment-of-intangible-assets-indefinitelived-excluding-goodwill https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/impairment-of-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/income-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/income-tax-examination-liability-refund-adjustment-from-settlement-with-taxing-authority https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/income-taxes-paid https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-deferred-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-other-deferred-liability https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/increase-in-restricted-cash https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/insider-transactions-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-costs-capitalized https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-expense-debt-excluding-amortization https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-paid https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-paid-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/interest-payable-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/inventory-finished-goods-net-of-reserves https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/inventory-raw-materials-net-of-reserves https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/inventory-write-down https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/investment-income-interest https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/level-3-asset-transfers-into-level https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/level-3-asset-transfers-out-of-level https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/liability-for-uncertain-tax-positions-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/liability-for-uncertain-tax-positions-noncurrent https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/long-term-debt https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/long-term-purchase-commitment-amount https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-cash-from https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/net-income-loss-available-to-common-stockholders-diluted https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/number-of-operating-segments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/number-of-reportable-segments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/oci-available-for-sale-adjustment-net-of-tax-change https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/oci-net-of-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/oci-reclassification-adjustment-for-write-down-of-securities-net-of-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/operating-leases-rent-expense-sublease-rentals https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/option-indexed-to-issuers-equity-indexed-shares https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/option-indexed-to-issuers-equity-strike-price https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-current-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-employee-related-liabilities-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-income https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-noncash-income-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-noncurrent-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-payments-to-acquire-businesses https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/other-sales-revenue-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/paid-in-capital-equity-component-of-convertible-debt https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-for-restructuring https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-to-acquire-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-to-acquire-other-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/payments-to-acquire-short-term-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/proceeds-from-payments-for-other-financing-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/proceeds-from-sale-and-maturity-of-available-for-sale-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/production-related-impairments-or-charges https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/reclassification-from-accumulated-oci-current-period-net-of-tax https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/repayments-of-convertible-debt https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/restructuring-charges https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/restructuring-reserve https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/restructuring-reserve-current https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sales-discounts-returns-and-allowances-goods https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sales-revenue-goods-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sales-revenue-services-net https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-10-k https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-10-k405 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-10-q https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-15-12b https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-15-12g https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-25 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-25-nse https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-425 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-8-k https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-ars https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-certnas https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-ct-order https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-def-14a https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-defa14a https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-s-4 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-3asr https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/significant-change-in-utb-is-reasonably-possible-amount-of-unrecorded-benefit https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-term https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-nondeductible-expense-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-tax-contingencies https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-tax-contingencies-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-rate-reconciliation-tax-settlements-state-and-local https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-deductions-qualified-production-activities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-tax-contingencies https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-tax-contingencies-other https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/tax-reconciliation-tax-credits-research https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/unrealized-gain-loss-on-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/unrealized-gain-on-securities https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-change https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-decrease-from-current-year-positions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-decrease-from-settlements https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-increase-from-acquisition https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-increase-from-settlements https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/utb-that-would-impact-effective-tax-rate https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/valuation-allowances-and-reserves-balance https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/valuation-allowances-and-reserves-charged-to-other-accounts https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/valuation-allowances-and-reserves-deductions https://stock.noler.com/us/stock/cubist-pharmaceuticals-inc/valuation-allowances-and-reserves-reserves-of-businesses-acquired